Results 181 to 190 of about 6,939,801 (335)
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source
Response to Letter to Editor "Critical Response to the Comments on the Critical Issue of Infant and Child Mortality in Afghanistan". [PDF]
Chirumbolo S.
europepmc +1 more source
Critical response of elastic-plastic SDOF systems with nonlinear viscous damping under simulated earthquake ground motions. [PDF]
Tamura G, Kojima K, Takewaki I.
europepmc +1 more source
VO2 Responses to Running Speeds Above Intermittent Critical Speed
Rafael Alves de Aguiar +3 more
openalex +2 more sources
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto +13 more
wiley +1 more source
A critical Response to "How firearm legislation impacts firearm mortality", A focused look at Canadian and Australian evidence. [PDF]
Langmann C.
europepmc +1 more source
Systems pharmacology using mass spectrometry identifies critical response nodes in prostate cancer. [PDF]
Ebhardt HA +5 more
europepmc +1 more source

